Ole e 7 is a nonspecific lipid transfer protein (nsLTP) allergen derived from olive pollen (Olea europaea), a major allergenic source in Mediterranean and Californian regions. The corresponding IgE antibodies (Ole e 7-specific IgE) are critical markers for diagnosing olive pollen allergy and associated pollen-food syndromes. This allergen belongs to the pan-allergen nsLTP family, known for its resistance to heat and digestion, enabling cross-reactivity with structurally similar proteins in foods like peach (Pru p 3) and other plant-derived allergens .
High-Exposure Regions: Ole e 7 IgE positivity reaches 47–60% in olive-sensitive populations .
Co-Sensitization: Over 50% of patients tested for Ole e 7 and Pru p 3 exhibit co-sensitization, despite no cross-reactivity .
Respiratory: Severe rhinitis, asthma exacerbation, and anaphylaxis linked to high pollen exposure .
Food Allergy: Cross-reactivity with Pru p 3 triggers peach-linked oral allergy syndrome (OAS) and anaphylaxis .
Recombinant Allergens: rOle e 7 retains natural allergenic properties, aiding precise IgE detection .
Minority Allergen Impact: In 2–7% of olive-sensitive patients, Ole e 7 IgE is the sole marker, necessitating targeted testing .
Ole e 7 is an allergen isolated from olive tree (Olea europaea) pollen that belongs to the nonspecific lipid transfer protein (nsLTP) family. It is a non-glycosylated protein with a molecular mass ranging between 9875 d to 10,297 d (approximately 9.5 kDa) . The allergen exhibits a high degree of polymorphism, which contributes to its varied immunological properties . Initial characterization through N-terminal sequencing of 21 amino acid residues from two isoforms revealed no homology with proteins contained in database banks at the time of its initial isolation .
Ole e 7 is distinct from other olive pollen allergens such as Ole e 1 (the major olive pollen allergen), Ole e 2 (profilin), Ole e 9 (glucanase), and Ole e 10. While Ole e 1 can act as an immunological marker for sensitivity against the Oleaceae family, Ole e 7 belongs to a highly conserved protein family found in both phylogenetically related and unrelated species . This conservation pattern explains its cross-reactivity potential with nsLTPs from other sources, including non-pollen allergens.
The isolation of Ole e 7 involves a multi-step purification process. The recommended protocol includes:
Initial extraction of olive pollen proteins
Fractionation using gel filtration chromatography
Further purification by reverse-phase HPLC
Verification of allergenic fractions using immunoblotting and ELISA with sera from olive-allergic patients
This purification strategy has been validated and can serve as a model for isolating other allergens with similar properties. For detection in patient samples, specific IgE (sIgE) assays using commercial systems such as ImmunoCAP are effective, with levels >0.35 kU/L considered positive .
Molecular characterization of Ole e 7 isoforms requires several complementary techniques:
Acid hydrolysis followed by amino acid analysis to determine composition
Mass spectrometry for accurate molecular weight determination, especially important given the polymorphic nature of Ole e 7
N-terminal sequencing via Edman degradation to identify sequence variations
Recombinant production of Ole e 7 variants for structural studies and immunological comparisons
For comprehensive epitope mapping, novel immunocapture approaches coupled with liquid chromatography and high-resolution mass spectrometry have proven effective in identifying IgE-binding linear epitopes .
To assess the biological activity of Ole e 7 and its potential cross-reactivity:
Basophil Activation Test (BAT): This cellular assay measures the release of mediators from basophils when stimulated with the allergen. The protocol typically uses recombinant Ole e 7 at 10 μg/mL as the stimulus, with cell staining performed using anti-human CD63 FITC/CD123 PE/HLA-DR PerCP antibody cocktail. PBS serves as a negative control and N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a positive control .
IgE-binding assays: Microplates coated with purified mouse anti-human IgE (0.2 μg/well) are used to capture IgE from patient sera. After blocking and washing steps, the plates are incubated with Ole e 7 peptides to assess binding capacity .
These functional assays provide critical information about the allergen's ability to trigger allergic responses and its cross-reactivity potential.
Ole e 7 sensitization has been significantly associated with more severe clinical manifestations of olive pollen allergy. Research indicates that patients with Ole e 7-specific IgE antibodies often experience more intense allergic responses, including anaphylactic reactions . This association with severity makes Ole e 7 sensitization an important clinical marker for risk assessment in olive pollen allergy management.
Additionally, in high-exposure areas supporting olive pollen counts over 5000 grains/m³, laboratory data show a positivity rate of 72% for Ole e 7-specific IgE , further highlighting its clinical relevance in regions with significant olive cultivation.
To investigate the relationship between Ole e 7 sensitization and asthma severity, researchers should employ a multifaceted approach:
Comprehensive clinical assessment: Document detailed patient history including symptom frequency, severity, medication use, and exacerbation patterns
Specific IgE quantification: Measure Ole e 7-specific IgE levels using standardized immunoassays
Pulmonary function testing: Assess objective measures of airway obstruction
Controlled exposure studies: In appropriate settings, monitor respiratory responses following controlled exposure to purified allergen components
Longitudinal follow-up: Track asthma days and symptom severity over time
Previous studies have demonstrated that patients with Ole e 7-specific IgE antibodies experience significantly more severe bronchial asthma compared to non-sensitized individuals, with higher numbers of asthma days (comparable to findings with Ole e 10 sensitization) .
When designing studies to investigate Ole e 7's role in pollen-food allergy syndrome, researchers should:
Establish clear patient categorization: Based on sensitization profiles (e.g., monosensitized to Ole e 7, monosensitized to food LTPs like Pru p 3, or sensitized to both)
Implement comprehensive diagnostic protocols:
Detailed clinical history focusing on both respiratory and food-related symptoms
Skin prick testing with both pollen and food allergens
Specific IgE quantification to relevant allergens
Basophil activation tests to assess cross-reactivity
Perform controlled food challenges: Under medical supervision in appropriate cases
Analyze geographic and environmental variables: Particularly olive pollen exposure levels
Consider genetic factors: Such as HLA haplotyping which may influence sensitization patterns
Research has shown that anti-Ole e 7 IgE is significantly associated with fruit anaphylaxis , and in areas with high olive pollen counts, more than half of patients tested for both Ole e 7 and Pru p 3 (peach LTP) are co-sensitized .
To identify cross-reactive epitopes between Ole e 7 and other nsLTPs (such as Pru p 3 from peach), researchers should employ:
Epitope mapping techniques:
Novel immunocapture approaches
Liquid chromatography coupled to high-resolution mass spectrometry
Peptide microarrays with overlapping synthetic peptides covering the entire sequence
Inhibition assays:
ELISA inhibition using recombinant proteins
Immunoblot inhibition to confirm shared epitopes
In vitro cellular assays:
Basophil activation tests with recombinant allergens (rOle e 7 and rPru p 3)
T-cell proliferation assays to assess T-cell epitope cross-recognition
A previous study found that 30% of patients sensitized to Ole e 7 without detectable sIgE to Pru p 3 showed positive BAT results when stimulated with recombinant Pru p 3, indicating potential cross-reactivity at the effector cell level despite the absence of detectable cross-reactive IgE .
Distinguishing between true cross-reactivity and co-sensitization requires a systematic approach:
Sequential immunoadsorption studies:
Pre-adsorb patient sera with one allergen before testing reactivity to the other
Compare binding patterns before and after adsorption
Recombinant allergen testing:
Use of purified recombinant allergens in both in vitro and in vivo tests
Site-directed mutagenesis of potential cross-reactive epitopes
Epitope-specific antibody analysis:
Production of monoclonal antibodies against specific epitopes
Competitive binding assays with different nsLTPs
Clinical correlation:
Compare clinical reactivity patterns with immunological findings
Assess symptom provocation with different allergens
Data from studies categorizing patients based on Ole e 7 and Pru p 3 sIgE profiles (monosensitized to Ole e 7, monosensitized to Pru p 3, or sensitized to both) provide a framework for such investigations .
To characterize Ole e 7 polymorphisms and assess their impact on allergenicity, researchers should:
Implement comprehensive protein sequencing:
Complete amino acid sequencing of multiple Ole e 7 isoforms
Mass spectrometry analysis to identify post-translational modifications
Conduct structural biology studies:
X-ray crystallography or NMR spectroscopy to determine 3D structures
Molecular modeling to predict the impact of sequence variations on protein folding
Perform comparative immunological testing:
IgE binding assays with different isoforms
Basophil activation tests to assess functional consequences of polymorphisms
T-cell epitope analysis to evaluate differences in immunological processing
Correlate genotypic and phenotypic data:
Analyze the relationship between specific Ole e 7 variants and clinical manifestations
Investigate geographical distribution of different isoforms relative to sensitization patterns
Given that Ole e 7 exhibits a high degree of polymorphism , understanding how these variations affect allergenicity could provide important insights for diagnostic and therapeutic applications.
To investigate the immunological mechanisms of Ole e 7 in severe allergic reactions:
Animal models:
Develop murine models sensitized to Ole e 7
Evaluate respiratory and systemic responses to controlled challenges
Ex vivo human studies:
Analyze cytokine production profiles from peripheral blood mononuclear cells (PBMCs)
Assess basophil and mast cell activation thresholds using cells from sensitized patients
Immune profiling:
Characterize T-cell receptor repertoires in Ole e 7-reactive lymphocytes
Analyze IgE affinity and avidity to Ole e 7 in patients with different clinical phenotypes
Genetic association studies:
Investigate HLA associations with Ole e 7 sensitization and reaction severity
Examine single nucleotide polymorphisms (SNPs) in genes involved in allergic inflammation
Research has demonstrated that Ole e 7 sensitization is associated with more severe clinical symptoms in patients who have experienced anaphylactic reactions , suggesting unique immunological mechanisms that merit further investigation.
Transcriptomic and proteomic approaches offer powerful tools for investigating Ole e 7 expression:
RNA sequencing (RNA-Seq):
Compare Ole e 7 transcript levels across olive tree varieties
Analyze gene expression under different environmental conditions
Identify regulatory elements controlling allergen expression
Quantitative proteomics:
Use isotope-coded protein labeling (ICPL) or isobaric tags for relative and absolute quantitation (iTRAQ)
Measure Ole e 7 protein abundance in pollen from different cultivars
Identify post-translational modifications that may affect allergenicity
Single-cell analysis:
Characterize cell-specific expression patterns within pollen grains
Investigate developmental regulation of Ole e 7 production
Environmental influence assessment:
Monitor Ole e 7 expression under different climate conditions
Evaluate the impact of pollution, temperature, and humidity on allergen expression
These advanced approaches could help explain the observed variations in Ole e 7 prevalence among different geographical populations and potentially identify olive varieties with reduced allergenic potential for future agricultural considerations.